Fundamental Research has initiated coverage on Biome Grow (CSE:BIO) with a Buy rating and a fair value estimate of $1.25 per share. The report highlighted Biome Grow’s focus on the Atlantic provinces, stating that, “competition amongst LPs is less fierce,” and, “The company’s purposeful avoidance of Canada’s most LP dense provinces allows them to establish their brands across the Atlantic provinces, building a strong domestic base.” The report also higlighted the company’s supply agreement with Newfoundland, stating that it is, “one of the largest provincial supply agreements announced to date.”

Click here to access the report. 

As quoted in the Fundamental Research report:

With Biome, management intends to establish a cannabis business platform built upon risk-hedged production and a dominant presence in the Atlantic provinces. To hedge production risk, Biome has placed an emphasis on securing off-take and supply agreements prior to even beginning construction on production facilities, which they have successfully done in the province of Newfoundland.

On November 2, 2018, Biome secured a 24,000 kg, three-year supply agreement with the Newfoundland government, one of the largest provincial supply agreements to date. Note that multi-year supply agreements with provincial governments are exceptional, long-term economic agreements that are large-scale in nature and differ from provincial purchase orders. Provincial purchase orders are short-term, smaller orders made to secure near-term inventory, and almost all LPs receive provincial purchase orders on a recurring basis given short-term supply shortages. However, Biome’s supply agreement is one of only a rare few signed between an LP and a provincial government. in addition, the province agreed to issue Biome five retail storefront licenses, and we believe that there are very few provincial supply agreements that exhibit these features. The ability of Biome to secure such a significant contract, despite their relatively small size relative to other LPs, demonstrates the capability of Biome’s management, as well as the strength of Biome’s relationship with Atlantic Canada.


Click here to connect with Biome Grow Inc. (CSE:BIO) for an Investor Presentation.


Ayurcann Holdings Corp. (CSE: AYUR) (the “Company” or “Ayurcann”) an integrated Canadian extraction company specializing in the processing of cannabis and hemp for the production of oils and various derivative products, announces the granting of stock options and restricted share units.

The Company has announced that it has granted incentive stock options to directors, officers, employees and consultants of the Company to purchase an aggregate of 1,000,100 common shares under the Company’s Stock Option Plan. Each option is exercisable at a price of $0.16 per common share, expires three years from the date of grant and vest six months from the date of the grant.

Keep reading... Show less

A planned business merger between two leading cannabis producers hit a small delay this week as a critical vote got moved.

Meanwhile, a cannabis retail operator elected to celebrate 420 by auctioning a cannabis-themed digital art piece using blockchain technology.

Keep reading... Show less

Partnerships with Minardi Law , Minorities for Medical Marijuana, CultivatED, and the Georgia Justice Project will include clinics and virtual events across Florida , Georgia , and Massachusetts

Trulieve Cannabis Corp. (CSE: TRUL) (OTCQX: TCNNF) (“Trulieve” or “the Company”), a leading and top-performing cannabis company based in the United States announced today a series of expungment clinics located throughout south and central Florida as well as virtual events in Georgia and Massachusetts . The clinics are part of the Company’s celebration of the 50 th anniversary of 420.

Keep reading... Show less

Seth Rogen’s New Cannabis Brand are Now Available at Apothecarium Dispensaries in San Francisco , Berkeley and Capitola

The Apothecarium is offering cannabis from Houseplant, the cannabis lifestyle brand founded by Seth Rogen and Evan Goldberg at its five California dispensaries. The Apothecarium has three San Francisco locations (Castro, SOMA and Marina ) and one each in Berkeley and Capitola (outside of Santa Cruz ).

Keep reading... Show less